
Get access to all handy features included in the IVIS website
- Get unlimited access to books, proceedings and journals.
- Get access to a global catalogue of meetings, on-site and online courses, webinars and educational videos.
- Bookmark your favorite articles in My Library for future reading.
- Save future meetings and courses in My Calendar and My e-Learning.
- Ask authors questions and read what others have to say.
Copper-Associated Hepatitis in Dogs
Get access to all handy features included in the IVIS website
- Get unlimited access to books, proceedings and journals.
- Get access to a global catalogue of meetings, on-site and online courses, webinars and educational videos.
- Bookmark your favorite articles in My Library for future reading.
- Save future meetings and courses in My Calendar and My e-Learning.
- Ask authors questions and read what others have to say.
Read
Copper-associated hepatitis resulting from copper overload has been well documented in Bedlington Terriers for many years now - and the faulty gene has now been almost eliminated - but other breeds can still be at risk, as Hille Fieten discusses in her paper.
Hille Fieten
DVM, PhD, Dipl. ECVIM-CA, MSc (genetic epidemiology)
After graduating from Utrecht University in 2006, Dr. Fieten obtained her Masters degree in genetic epidemiology at Erasmus University in 2011 before studying for her PhD, which focused on copper-associated hepatitis in Labrador Retrievers. She currently works as an internal medicine specialist at Utrecht University with a focus on hepatology, and she is the president for the Society of Comparative Hepatology. She was recently appointed director of the Expertise Center Genetics for Companion Animals, which aims to decrease the incidence of hereditary disease in dogs and cats.

Key Points
- Copper-associated hepatitis is a hereditary disease present in a number of dog breeds; the dietary levels of copper and the copper:zinc ratio influence copper levels in the liver.
- To determine copper status in a dog, a histological liver biopsy with quantitative copper measurement is needed.
- Treatment consists of feeding a low copper/high zinc diet and using D-penicillamine to chelate the copper; longterm dietary management may be an effective supportive measure to delay copper re-accumulation in the liver.
- Lifelong, continuous chelation therapy is, except in the Bedlington Terrier, not recommended due to the risk of copper and zinc deficiencies developing.
Introduction
Copper is an essential trace element which plays a vital role in a wide variety of biological processes. However, in excessive amounts copper is extremely toxic, because free copper ions can generate reactive oxygen species that damage proteins, lipids and DNA. In order to prevent toxic effects, copper homeostasis in the body is tightly regulated by many different copper-binding proteins (1). Copper contained in food or drinking water is absorbed via the gastrointestinal (GI) tract. At the basolateral side of the enterocytes, the copper transporter ATP7A is responsible for the movement of copper across the basolateral membrane into the portal circulation (Figure 1). Through the portal system copper reaches the liver, which has a central role in the metabolism, storage and excretion of the element. Within the hepatocytes, copper is chaperoned to distinct cellular organelles and incorporated into proteins to exert its different functions. Hepatocytes also have a storage function for copper and regulate redistribution of copper to other organs in the body. Excess copper is transported over the canalicular apical membrane of the hepatocytes and excreted in the bile. The copper transporter ATP7B, which is structurally related to ATP7A, plays an important role in this excretion process (Figure 1). The protein COMMD1 is believed to be important for proper functioning of ATP7B in the process of biliary excretion of excess copper. The importance of the transporters ATP7A and ATP7B in copper homeostasis is illustrated by the disruptive effects of hereditary defects in each of these proteins in human patients. Babies and children with mutations in ATP7A develop Menkes disease, a lethal disease that is characterized by a severe copper-deficiency phenotype, with neurological defects (2). Mutations in ATP7B cause Wilson disease in humans, whereby copper overload in the liver and neuronal tissues results in liver failure and/or neurological or mental disease (3). [...]

Figure 1. The diagram shows how copper uptake and excretion is regulated by ATP7A and ATP7B transporters. ATP7A located at the basolateral membrane of enterocytes facilitates uptake of copper from the enterocytes into the portal circulation. Subsequently, copper is taken up by hepatocytes and excess copper is excreted via the bile, a process facilitated by ATP7B. In Bedlington Terriers a deletion in the COMMD1 gene results in complete absence of the COMMD1 protein in the liver, with subsequent decreased copper excretion into the bile. In the Labrador Retriever a combination of mutations in the ATP7A and ATP7B proteins may influence copper homeostasis (5). Copper accumulation in the liver will occur due to decreased function of the ATP7B protein caused by the ATPBR1453Q amino acid substitution. This effect will be attenuated if ATP7A function is concurrently hampered by substitution of the ATP7AT327I amino acid, which results in copper accumulating in the enterocytes and subsequent increased shedding of copper in the feces. The presence of the ATP7A mutation alone could theoretically predispose to copper deficiency.
Get access to all handy features included in the IVIS website
- Get unlimited access to books, proceedings and journals.
- Get access to a global catalogue of meetings, on-site and online courses, webinars and educational videos.
- Bookmark your favorite articles in My Library for future reading.
- Save future meetings and courses in My Calendar and My e-Learning.
- Ask authors questions and read what others have to say.
About
How to reference this publication (Harvard system)?
Affiliation of the authors at the time of publication
Faculty of Veterinary Medicine, University of Utrecht, The Netherlands.
Author(s)
Copyright Statement
© All text and images in this publication are copyright protected and cannot be reproduced or copied in any way.Related Content
Readers also viewed these publications
Subscribe
Access to the content of the Veterinary Focus website is reserved for animal health professionals. If you do not yet have a user account with Royal Canin you can create a free account by selecting the New User form. Subscription to the journal is free and issues in your preferred language can be obtained at the Veterinary Focus website.

Comments (0)
Ask the author
0 comments